Generic Name: Carbidopa-Levodopa
Sinemet® is a brand name for the combination of the drugs levodopa and carbidopa. The combination is used to treat the symptoms of Parkinson's disease or Parkinson-like symptoms. Sinemet® dosage options available include 10/100mg; 25/100mg; 25/250mg.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat Parkinson's | 264 |
|
|
|
40 | ||
| Stiffness/Spasticity | 25 |
|
|
3 | |||
| Slowness | 18 |
|
2 | ||||
| Other | 14 |
|
|
3 | |||
| Tremors | 12 |
|
|
|
6 | ||
| Treat my MSA | 9 |
|
|
2 |
See all 388 patients currently taking Sinemet
Mouse over the table for more information
Top 10 dosages based on patients currently taking Sinemet. See all 104 dosages ►
| 10mg-100mg as needed | 10mg as needed | 11 x 25 mg-100 mg all the time (24/7) | 1other as needed | 25 mg-100 mg all the time (24/7) | 25mg-100mg as needed | 25 mg-250 mg as needed | 25mg as needed | 2.5 x 25 mg-100 mg all the time (24/7) | 2 x 10 mg-100 mg all the time (24/7) | 2 x 25 mg-100 mg all the time (24/7) | 3 25mg-100mg as needed | 3 x 25 mg-100 mg all the time (24/7) | 4 x 25 mg-100 mg all the time (24/7) | 7 25mg-250mg as needed | 8 25mg-250mg as needed | daily | 0.25 mg daily | 0.5 mg daily | 1 mg daily | 1.5 other daily | 2 mg daily | 2 tbs. daily | 3 mg daily | 3 other daily | 4 mg daily | 4.5 mg daily | 5 mg daily | 6 mg daily | 8 mg daily | 12.5 mg daily | 15 mg daily | 20 mg daily | 25 mg daily | 25 tbs. daily | 25.1 mg daily | 37.5 mg daily | 50 mg daily | 60 mg daily | 25 mg-100 mg one time | 75 mg daily | 100 mg daily | 10 mg-100 mg daily | 25 mg-100 mg daily | 115 mg daily | 125 mg daily | 25 mg-250 mg daily | 150 mg daily | 1.5 x 25 mg-100 mg daily | 1.75 x 25 mg-100 mg daily | 200 mg daily | 2 x 10 mg-100 mg daily | 2 x 25 mg-100 mg daily | 225 mg daily | 250 mg daily | 25 mg-250 mg daily | 300 mg daily | 3 x 10 mg-100 mg daily | 3 x 25 mg-100 mg daily | 3.5 x 25 mg-100 mg daily | 1.5 x 25 mg-250 mg daily | 375 mg daily | 400 mg daily | 4 x 10 mg-100 mg daily | 4 x 25 mg-100 mg daily | 4.5 x 25 mg-100 mg daily | 500 mg daily | 5 x 25 mg-100 mg daily | 525 mg daily | 5.5 x 25 mg-100 mg daily | 600 mg daily | 6 x 10 mg-100 mg daily | 6 x 25 mg-100 mg daily | 625 mg daily | 660 mg daily | 700 mg daily | 7 x 25 mg-100 mg daily | 3 x 25 mg-250 mg daily | 750 mg daily | 800 mg daily | 8 x 10 mg-100 mg daily | 8 x 25 mg-100 mg daily | 900 mg daily | 9 x 25 mg-100 mg daily | 120 x 25 mg-250 mg monthly | 1000 mg daily | 10 x 25 mg-100 mg daily | 4 x 25 mg-250 mg daily | 10.5 x 25 mg-100 mg daily | 11 x 25 mg-100 mg daily | 4.5 x 25 mg-250 mg daily | 1200 mg daily | 12 x 25 mg-100 mg daily | 5 x 25 mg-250 mg daily | 13 x 25 mg-100 mg daily | 13.5 x 25 mg-100 mg daily | 14 x 25 mg-100 mg daily | 1500 mg daily | 15 x 25 mg-100 mg daily | 6 x 25 mg-250 mg daily | 16 x 25 mg-100 mg daily | 20 x 25 mg-100 mg daily | 9 x 25 mg-250 mg daily | 1100 x 25 mg-100 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
24
|
1
|
1
|
3
|
1
|
1
|
1
|
4
|
1
|
5
|
1
|
2
|
4
|
2
|
1
|
1
|
1
|
18
|
1
|
1
|
2
|
5
|
1
|
1
|
14
|
11
|
1
|
19
|
1
|
4
|
1
|
4
|
1
|
1
|
6
|
2
|
19
|
1
|
6
|
1
|
8
|
2
|
35
|
3
|
2
|
2
|
6
|
1
|
21
|
2
|
6
|
15
|
1
|
1
|
3
|
1
|
23
|
1
|
1
|
1
|
7
|
2
|
1
|
4
|
2
|
9
|
3
|
4
|
1
|
4
|
3
|
4
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
16 | 39% |
|
|
Other
|
13 | 32% |
|
|
Did not seem to work
|
10 | 24% |
|
|
Side effects too severe
|
7 | 17% |
|
|
Course of treatment ended
|
2 | 5% |
|
|
Not indicated
|
2 | 5% |
|
|
Personal research
|
1 | 2% |
|
|
Expense
|
1 | 2% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.